Rapamycin and wortmannin enhance replication of a defective encephalomyocarditis virus
about
Picornaviruses and nuclear functions: targeting a cellular compartment distinct from the replication site of a positive-strand RNA virusEap1p, a novel eukaryotic translation initiation factor 4E-associated protein in Saccharomyces cerevisiae.The encephalomyocarditis virusEncephalomyocarditis virus 2A protein is required for viral pathogenesis and inhibition of apoptosisSuppression of injuries caused by a lytic RNA virus (mengovirus) and their uncoupling from viral reproduction by mutual cell/virus disarmament.Deletion mapping of the encephalomyocarditis virus primary cleavage site.Translational control of viral gene expression in eukaryotesLocal translation of RhoA regulates growth cone collapse.Mutational analysis of the EMCV 2A protein identifies a nuclear localization signal and an eIF4E binding site.Binding interactions between the encephalomyocarditis virus leader and protein 2A.Stimulation of picornavirus replication by the poly(A) tail in a cell-free extract is largely independent of the poly(A) binding protein (PABP).Cardiovirus 2A protein associates with 40S but not 80S ribosome subunits during infection.CCR5-Dependent Activation of mTORC1 Regulates Translation of Inducible NO Synthase and COX-2 during Encephalomyocarditis Virus Infection.Site-specific cleavage of the host poly(A) binding protein by the encephalomyocarditis virus 3C proteinase stimulates viral replication.Cell-free synthesis of encephalomyocarditis virus.Antiapoptotic activity of the cardiovirus leader protein, a viral "security" protein.Eukaryotic translation initiation factor 4E availability controls the switch between cap-dependent and internal ribosomal entry site-mediated translation.VPg unlinkase/TDP2 in cardiovirus infected cells: Re-localization and proteolytic cleavage.
P2860
Q26825450-2926DC04-DCBC-43B8-B31F-3CA795FFD4B9Q27932207-AD6F0DD9-90E0-4DBC-BB0D-CFF6B80D5943Q28715925-D5F9730E-BC75-42B1-960B-020D156A7186Q28744244-8359C214-A27A-4FE6-8B3B-CFD909555574Q30513987-C20D893B-3974-4F0D-81AD-8FA0A4CFBCA4Q33844859-F9AE1692-351A-46EC-9E87-129F3161FCFDQ33935121-9F6891A8-12BC-4CF2-AD65-193627ED56FEQ34231454-0A526755-5764-4908-A068-211227EBE65AQ34491180-8870DE50-A7B5-4984-9488-EA99BC621FD8Q34594665-AFD3BA02-3796-46F4-A243-26A14F37F121Q36148355-FB6550D2-E4D0-4AB6-A824-5AED0CCFFCEEQ36315741-8A0455AB-F77B-425F-9B2B-E8569CF31D88Q38832326-70DA14C8-4A3A-4730-AF10-368F38C87ED0Q39307519-54F70D3A-DC46-4904-830F-FB32584ED90BQ39752491-02B599E9-D3E2-4835-8638-4AD8E85DD289Q39855956-5B7D40B0-A7CF-46E3-ADD2-4A7B5F061237Q39891152-7DD5ADFA-A72B-4868-B3C9-3626021C2595Q52735526-131382AA-BBE5-42AA-A5A8-43A34182841E
P2860
Rapamycin and wortmannin enhance replication of a defective encephalomyocarditis virus
description
1998 nî lūn-bûn
@nan
1998 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Rapamycin and wortmannin enhance replication of a defective encephalomyocarditis virus
@ast
Rapamycin and wortmannin enhance replication of a defective encephalomyocarditis virus
@en
type
label
Rapamycin and wortmannin enhance replication of a defective encephalomyocarditis virus
@ast
Rapamycin and wortmannin enhance replication of a defective encephalomyocarditis virus
@en
prefLabel
Rapamycin and wortmannin enhance replication of a defective encephalomyocarditis virus
@ast
Rapamycin and wortmannin enhance replication of a defective encephalomyocarditis virus
@en
P2093
P2860
P1433
P1476
Rapamycin and wortmannin enhance replication of a defective encephalomyocarditis virus
@en
P2093
A C Gingras
A C Palmenberg
N Sonenberg
Y V Svitkin
P2860
P304
P577
1998-07-01T00:00:00Z